IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Adial Pharmaceuticals Inc

CUSIP: 00688A106 | 55 institutional holders

Quarters

Q1 2025Q4 2024Q2 2023Q1 2023Q4 2022
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2025

1620 Investment Advisors, Inc.3,600
0.0% of portfolio›$2.3K
StyleTurnoverLocationFiled
1620 Investment Advisors, Inc.
3,600$2.3K0.0%ValueLowPlymouth, MA2025-05-14